A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases
Clinical trial NCT07144462 · RECRUITING
Trial details
- NCT number
- NCT07144462
- Sponsor
- Neukio Biotherapeutics (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-04
- Primary completion
- 2027-01-14
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.